These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21654614)

  • 1. Pharmacological profile of estrogens in oral contraception.
    Bitzer J
    Minerva Ginecol; 2011 Jun; 63(3):299-304. PubMed ID: 21654614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovulation inhibition by estetrol in an in vivo model.
    Coelingh Bennink HJ; Skouby S; Bouchard P; Holinka CF
    Contraception; 2008 Mar; 77(3):186-90. PubMed ID: 18279689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological aspects of oral contraceptives (author's transl)].
    Weil-levy C; Soubrie C; Simon P
    Contracept Fertil Sex (Paris); 1980 Feb; 8(2):123-7. PubMed ID: 12336185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral contraception: advantages of estrogen reduction].
    Cohen J
    Contracept Fertil Sex (Paris); 1993 Jun; 21(6):489-94. PubMed ID: 12318239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mode of action and biologic effects of steroid inhibitors of ovulation].
    Chevallier G
    Presse Med (1893); 1967 Mar; 75(11):533-8. PubMed ID: 4163865
    [No Abstract]   [Full Text] [Related]  

  • 7. [Post-coital contraception].
    Serfaty D
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):359-64. PubMed ID: 12280207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of estetrol, a selective nuclear estrogen receptor modulator, in mouse models of arterial and venous thrombosis.
    Valéra MC; Noirrit-Esclassan E; Dupuis M; Fontaine C; Lenfant F; Briaux A; Cabou C; Garcia C; Lairez O; Foidart JM; Payrastre B; Arnal JF
    Mol Cell Endocrinol; 2018 Dec; 477():132-139. PubMed ID: 29928930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calciumantagonistic effect of natural and synthetic estrogens--investigations on a nongenomic mechanism of direct vascular action.
    Mueck AO; Seeger H; Lippert TH
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):424-6. PubMed ID: 8897079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application.
    Elger W; Schwarz S; Hedden A; Reddersen G; Schneider B
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):395-403. PubMed ID: 8541236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Estrogens in contraception].
    Lauritzen C
    Wien Med Wochenschr; 1987 Oct; 137(18-19):427-32. PubMed ID: 3318154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogenic profile on a water-soluble estrogen, estrazinol hydrobromide.
    Rassaert CL; DiPasquale G; Giannina T; Manning JP; Meli A
    Steroids Lipids Res; 1973; 4(5):333-40. PubMed ID: 4368700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies on the low-dosage norgestrel-ethinylestradiol combination as a long term oral contraception (author's transl)].
    Higashiyama S; Obata T; Kizu S; Nakano Y; Iwasaki T
    Nihon Funin Gakkai Zasshi; 1974 Jan; 19(1):40-53. PubMed ID: 4478810
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral contraceptives and blood coagulation.
    Bonnar J; Sabra AM
    J Reprod Med; 1986 Jun; 31(6 Suppl):551-6. PubMed ID: 2941571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogens in oral contraceptives: historical perspectives.
    Goldzieher JW
    Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral contraception: disadvantages of estrogen reduction].
    Denis C
    Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estetrol and the possibilities of its clinical use.
    Křepelka Petr
    Ceska Gynekol; 2021; 86(3):217-221. PubMed ID: 34167315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen.
    Regidor PA; Mueller A; Mayr M
    Womens Health (Lond); 2023; 19():17455057221147388. PubMed ID: 36744531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins.
    White T; Ozel B; Jain JK; Stanczyk FZ
    Contraception; 2006 Oct; 74(4):293-6. PubMed ID: 16982228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between effects of estradiol valerate and low dose ethinyl estradiol on haemostasis parameters.
    Lindberg UB; Crona N; Stigendal L; Teger-Nilsson AC; Silfverstolpe G
    Thromb Haemost; 1989 Feb; 61(1):65-9. PubMed ID: 2526387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.